Atomo Diagnostics Ltd. · ASX:AT1

Atomo Diagnostics — FY2025 Earnings Presentation

26 slides from Atomo Diagnostics's earnings presentation, Aug 29, 2025

  1. Slide 1: FY25 Results Presentation

    For personal use only ATOMO DIAGNOSTICS FY25 RESULTS PRESENTATION 29 AUGUST 2025

  2. Slide 2: For personal use only

    For personal use only ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 2

  3. Slide 3: Who is Atomo? What do we do?

    WHO IS ATOMO? WHAT DO WE DO? For personal use only • • • • • • • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 3

  4. Slide 4: Board renewal, capital activities, focus on opex and burn rate

    BOARD RENEWAL CAPITAL ACTIVITIES TO SUPPORT BALANCE SHEET CONTINUED FOCUS ON OPEX & BURNRATE For personal use only • • • • • • • • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 4

  5. Slide 5: Commercial Deliverables

    COMMERCIAL DELIVERABLES ATOMO FINISHED TEST BUSINESS ATOMO OEM TECHNOLOGIES BUSINESS For personal use only • • • • • • • • • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 5

  6. Slide 6: FY 2025 Financials

    For personal use only FY 2025 FINANCIALS

  7. Slide 7: Profit & Loss

    5 PROFIT & LOSS For personal use only • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 7

  8. Slide 8: FY25 vs FY24 results

    For personal use only FY25 FY24 • AUD ($m) ($m) • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 8

  9. Slide 9: FY25 Cashflow Activities

    • For personal use only FY25 Cashflow Activities (A$’m) • 14.00 • • 12.00 10.00 • 8.00 • 6.00 • • 4.00 • 2.00 0.00 • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 9

  10. Slide 10: Well positioned for profitability with no need for significant CapEx

    Well positioned for profitability with no need for significant CapEx to fund future revenue growth and continued on-going trends to breakeven For personal use only 2.5 6 2 5 1.5 4 1 3 0.5 2 0 1 0 POC Tests POC Technology Development fees/other • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 10

  11. Slide 11: Atomo HIV Self-Test

    For personal use only ATOMO HIV SELF-TEST A LEADING TEST IN KEY MARKETS

  12. Slide 12: Two key drivers of long-term growth

    ATOMO IS SEEING TWO KEY DRIVERS OF LONG-TERM GROWTH: For personal use only o Expansion of channel interest across Pharmacy/Retail post COVID o Emergence of Public Health Procurement for HIV Self-Testing • • • • • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 12

  13. Slide 13: For personal use only

    For personal use only • • • • • • • • • • ANZ • • • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 13

  14. Slide 14: Atomo Active Syphilis

    For personal use only ATOMO ACTIVE SYPHILIS A UNIQUE TEST TO IDENTIFY ACTIVE INFECTION AT THE POINT-OF-CARE

  15. Slide 15: Atomo's Active Syphilis Test

    ATOMO’S ACTIVE SYPHILIS TEST ≤ • For personal use only µ µ • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 15

  16. Slide 16: For personal use only

    For personal use only • • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 16

  17. Slide 17: For personal use only

    For personal use only µ µ µ β ≥ β ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 17

  18. Slide 18: Benefits and intended use of Atomo Active Syphilis

    BENEFITS OF ATOMO ACTIVE SYPHILIS INTENDED USE OF THE TEST For personal use only • µ • • ‐ • KOL FEEDBACK TIMELINE ON DEVELOPMENT • • • • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 18

  19. Slide 19: OEM Technology: Pascal and Florey

    For personal use only OEM TECHNOLOGY PASCAL AND FLOREY

  20. Slide 20: Clinically validated performance

    45° IQ2 360° CLINICALLY VALIDATED PERFORMANCE For personal use only • • • IQ1 Y • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 20

  21. Slide 21: Three key factors driving ease of use

    THE THREE KEY FACTORS DRIVING EASE OF USE: WHERE ATOMO EXCELS: CLINICIAN & USER FEEDBACK For personal use only ADOPTION OF RAPID TESTS: Independent Report - Comparative usability analysis of Atomo Pascal vs Commercialised Blood Self-Test kit [Source] ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private an

  22. Slide 22: For personal use only

    ) x For personal use only • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 22

  23. Slide 23: Internal chamber can be resized for swabs

    ) INTERNAL CHAMBER CAN BE RESIZED & OPTOMISED FOR NASAL, For personal use only ORAL AND VAGINAL SWABS 360° IQ2 IQ1 Y ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) 23

  24. Slide 24: Summary

    For personal use only SUMMARY

  25. Slide 25: Investment Highlights

    INVESTMENT HIGHLIGHTS • For personal use only • • • • • • • • • • • • • ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 25

  26. Slide 26: For personal use only

    For personal use only ATOMO DIAGNOSTICS LIMITED | (ASX: AT1) Private and Confidential 26

Atomo Diagnostics — FY2025 Earnings Presentation on 6ix